| An interdigit signalling centre instructs coordinate phalanx-joint formation governed by 5′ Hoxd–Gli3 antagonism BL Huang, A Trofka, A Furusawa, JL Norrie, AH Rabinowitz, SA Vokes, ... Nature communications 7 (1), 12903, 2016 | 50 | 2016 |
| CD29 targeted near-infrared photoimmunotherapy (NIR-PIT) in the treatment of a pigmented melanoma model A Furusawa, R Okada, F Inagaki, H Wakiyama, T Kato, H Furumoto, ... Oncoimmunology 11 (1), 2019922, 2022 | 17 | 2022 |
| Combined CD44-and CD25-targeted near-infrared photoimmunotherapy selectively kills cancer and regulatory T cells in syngeneic mouse cancer models Y Maruoka, A Furusawa, R Okada, F Inagaki, D Fujimura, H Wakiyama, ... Cancer immunology research 8 (3), 345-355, 2020 | 57 | 2020 |
| Comparison of the Effectiveness of IgG Antibody versus F(ab′)2 Antibody Fragment in CTLA4-Targeted Near-Infrared Photoimmunotherapy T Kato, R Okada, A Furusawa, H Wakiyama, H Furumoto, H Fukushima, ... Molecular pharmaceutics 19 (10), 3600-3611, 2022 | 5 | 2022 |
| Concurrent Mutations in ATM and Genes Associated with Common γ Chain Signaling in Peripheral T Cell Lymphoma HM Simpson, RZ Khan, C Song, D Sharma, K Sadashivaiah, A Furusawa, ... PloS one 10 (11), e0141906, 2015 | 24 | 2015 |
| Conjugation ratio, light dose, and pH affect the stability of panitumumab–IR700 for near-infrared photoimmunotherapy D Fujimura, F Inagaki, R Okada, A Rosenberg, A Furusawa, PL Choyke, ... ACS Medicinal Chemistry Letters 11 (8), 1598-1604, 2020 | 14 | 2020 |
| Cyanine Phototruncation Enables Cell Labeling with Spatiotemporal Control H Fukushima, S Matikonda, S Usama, A Furusawa, T Kato, L Štacková, ... | | 2022 |
| Cyanine phototruncation enables spatiotemporal cell labeling H Fukushima, SS Matikonda, SM Usama, A Furusawa, T Kato, ... Journal of the American Chemical Society 144 (25), 11075-11080, 2022 | 23 | 2022 |
| Deletion of SNAP-23 results in pre-implantation embryonic lethality in mice YH Suh, A Yoshimoto-Furusawa, KA Weih, L Tessarollo, KW Roche, ... PloS one 6 (3), e18444, 2011 | 43 | 2011 |
| Diagnostic imaging in near‐infrared photoimmunotherapy using a commercially available camera for indocyanine green FF Inagaki, D Fujimura, A Furusawa, R Okada, H Wakiyama, T Kato, ... Cancer Science 112 (3), 1326-1330, 2021 | 15 | 2021 |
| Disialoganglioside GD2-targeted near-infrared photoimmunotherapy (NIR-PIT) in tumors of neuroectodermal origin FF Inagaki, T Kato, A Furusawa, R Okada, H Wakiyama, H Furumoto, ... Pharmaceutics 14 (10), 2037, 2022 | 7 | 2022 |
| Effect of short PEG on near-infrared BODIPY-based activatable optical probes FF Inagaki, D Fujimura, S Ansteatt, R Okada, A Furusawa, PL Choyke, ... ACS omega 5 (25), 15657-15665, 2020 | 8 | 2020 |
| Electron donors rather than reactive oxygen species needed for therapeutic photochemical reaction of near-infrared photoimmunotherapy T Kato, R Okada, Y Goto, A Furusawa, F Inagaki, H Wakiyama, ... ACS pharmacology & translational science 4 (5), 1689-1701, 2021 | 23 | 2021 |
| Endoscopic applications of near-infrared photoimmunotherapy (NIR-PIT) in cancers of the digestive and respiratory tracts H Furumoto, T Kato, H Wakiyama, A Furusawa, PL Choyke, H Kobayashi Biomedicines 10 (4), 846, 2022 | 5 | 2022 |
| Endoscopic near‐infrared photoimmunotherapy in an orthotopic head and neck cancer model R Okada, A Furusawa, F Inagaki, H Wakiyama, T Kato, S Okuyama, ... Cancer Science 112 (8), 3041-3049, 2021 | 17 | 2021 |
| Enhanced nanodrug delivery in tumors after near-infrared photoimmunotherapy FF Inagaki, A Furusawa, PL Choyke, H Kobayashi Nanophotonics 8 (10), 1673-1688, 2019 | 20 | 2019 |
| Eomesodermin driven IL-10 production in effector CD8+ T cells promotes a memory phenotype J Reiser, K Sadashivaiah, A Furusawa, A Banerjee, N Singh Cellular immunology 335, 93-102, 2019 | 18 | 2019 |
| Eomesodermin increases survival and IL-2 responsiveness of tumor-specific CD8+ T cells in an adoptive transfer model of cancer immunotherapy A Furusawa, J Reiser, K Sadashivaiah, H Simpson, A Banerjee Journal of Immunotherapy 41 (2), 53-63, 2018 | 6 | 2018 |
| Eomesodermin is required for antitumor immunity mediated by 4-1BB-agonist immunotherapy C Song, K Sadashivaiah, A Furusawa, E Davila, K Tamada, A Banerjee Oncoimmunology 3 (2), e27680, 2014 | 31 | 2014 |
| Eomesodermin promotes a central memory phenotype in CD8+ T cells through the induction of IL-10. J Reiser, A Gerber, K Sadashivaiah, A Furusawa, A Banerjee, NJ Singh The Journal of Immunology 200 (1_Supplement), 51.15-51.15, 2018 | | 2018 |
